Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.13 USD | +0.97% | -9.74% | -16.00% |
Apr. 17 | Sector Update: Health Care Stocks Mixed Wednesday Afternoon | MT |
Apr. 17 | NeuroBo Begins Dosing in Phase 1 Study of Obesity Treatment; Shares Rise | MT |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 15.21M |
---|---|---|---|---|---|
Net income 2024 * | -26M | Net income 2025 * | -29M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.89
x | P/E ratio 2025 * |
-1.4
x | Employees | 8 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 38.33% |
1 day | +0.97% | ||
1 week | -9.74% | ||
Current month | -24.08% | ||
1 month | -29.19% | ||
3 months | -0.48% | ||
6 months | -9.74% | ||
Current year | -16.00% |
Managers | Title | Age | Since |
---|---|---|---|
Hyung-Heon Kim
CEO | Chief Executive Officer | 47 | 21-07-08 |
Director of Finance/CFO | 66 | 23-10-26 |
Members of the board | Title | Age | Since |
---|---|---|---|
D. Strickland
BRD | Director/Board Member | 77 | 22-01-26 |
Andrew Koven
CHM | Chairman | 66 | 21-07-08 |
Mark Glickman
BRD | Director/Board Member | 58 | 23-05-10 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 3.105 | +0.16% | 1 396 |
24-04-24 | 3.1 | +2.65% | 39,360 |
24-04-23 | 3.02 | -3.21% | 42,194 |
24-04-22 | 3.12 | -7.42% | 23,389 |
24-04-19 | 3.37 | -2.03% | 20,562 |
Delayed Quote Nasdaq, April 25, 2024 at 02:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.00% | 15.21M | |
-2.25% | 104B | |
+1.75% | 97.42B | |
+0.79% | 22.2B | |
-17.78% | 21.23B | |
-11.11% | 18.33B | |
-42.83% | 16.35B | |
-17.99% | 15.06B | |
+3.70% | 13.98B | |
+33.23% | 11.66B |
- Stock Market
- Equities
- NRBO Stock